Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1962 1
1966 1
1968 2
1970 2
1973 2
1976 1
1977 1
1978 2
1979 3
1980 2
1981 1
1982 1
1983 2
1984 3
1985 5
1986 1
1987 2
1988 3
1989 3
1990 6
1991 8
1992 3
1993 5
1994 4
1995 10
1996 16
1997 15
1998 17
1999 12
2000 12
2001 13
2002 14
2003 17
2004 14
2005 20
2006 23
2007 9
2008 6
2009 7
2010 7
2011 4
2012 8
2013 17
2014 13
2015 11
2016 15
2017 10
2018 8
2019 12
2020 12
2021 12
2022 20
2023 15
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Results by year

Filters applied: . Clear all
Page 1
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: muraoka m. Cancer Immunol Res. 2024 Mar 20. doi: 10.1158/2326-6066.CIR-23-0638. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38558120
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease.
Okura Y, Ikawa-Teranishi Y, Mizoroki A, Takahashi N, Tsushima T, Irie M, Harfuddin Z, Miura-Okuda M, Ito S, Nakamura G, Takesue H, Ozono Y, Nishihara M, Yamada K, Gan SW, Hayasaka A, Ishii S, Wakabayashi T, Muraoka M, Nagaya N, Hino H, Nemoto T, Kuramochi T, Torizawa T, Shimada H, Kitazawa T, Okazaki M, Nezu J, Sollid LM, Igawa T. Okura Y, et al. Among authors: muraoka m. Nat Commun. 2023 Dec 22;14(1):8502. doi: 10.1038/s41467-023-44083-4. Nat Commun. 2023. PMID: 38135691 Free PMC article.
Infant with respiratory distress and shock.
Tetsuhara K, Hayashida M, Muraoka M, Kano Z. Tetsuhara K, et al. Among authors: muraoka m. J Am Coll Emerg Physicians Open. 2023 Oct 10;4(5):e13049. doi: 10.1002/emp2.13049. eCollection 2023 Oct. J Am Coll Emerg Physicians Open. 2023. PMID: 37829767 Free PMC article. No abstract available.
Circle-to-W flap.
Yabe T, Takemura H, Muraoka M. Yabe T, et al. Among authors: muraoka m. Plast Reconstr Surg. 1999 Oct;104(5):1430-4. doi: 10.1097/00006534-199910000-00030. Plast Reconstr Surg. 1999. PMID: 10513930 No abstract available.
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.
Mikami H, Feng S, Matsuda Y, Ishii S, Naoi S, Azuma Y, Nagano H, Asanuma K, Kayukawa Y, Tsunenari T, Kamikawaji S, Iwabuchi R, Shinozuka J, Yamazaki M, Kuroi H, Ho SSW, Gan SW, Chichili P, Pang CL, Yeo CY, Shimizu S, Hironiwa N, Kinoshita Y, Shimizu Y, Sakamoto A, Muraoka M, Takahashi N, Kawa T, Shiraiwa H, Mimoto F, Kashima K, Kamata-Sakurai M, Ishikawa S, Aburatani H, Kitazawa T, Igawa T. Mikami H, et al. Among authors: muraoka m. Cancer Immunol Res. 2024 Apr 1:OF1-OF12. doi: 10.1158/2326-6066.CIR-23-0638. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38563577
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
Suzuki Y, Maekawa S, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Takada H, Muraoka M, Sato M, Takano S, Fukasawa M, Yamaguchi T, Funayama S, Morisaka H, Onishi H, Enomoto N. Suzuki Y, et al. Among authors: muraoka m. J Gastroenterol Hepatol. 2023 Jun;38(6):921-929. doi: 10.1111/jgh.16154. Epub 2023 Mar 5. J Gastroenterol Hepatol. 2023. PMID: 36811251
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Takada H, Yamashita K, Osawa L, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Takano S, Fukasawa M, Yamaguchi T, Maekawa S, Takahashi K, Uchimura K, Enomoto N. Takada H, et al. Among authors: muraoka m. Oncology. 2023;101(10):609-623. doi: 10.1159/000531111. Epub 2023 Jun 6. Oncology. 2023. PMID: 37279708
Otoplasty in microtia.
Muraoka M, Nakai Y, Shimada K, Yagi H, Nakaki Y. Muraoka M, et al. Acta Otolaryngol Suppl. 1991;486:176-83. doi: 10.3109/00016489109134994. Acta Otolaryngol Suppl. 1991. PMID: 1842865
415 results